The effect of angiotensin II type 2 receptor agonist treatment on doxorubicin induced heart failure

Basit Öğe Kaydı
dc.authoridParlakpinar, Hakan/0000-0001-9497-3468
dc.authoridParlakpınar, Hakan/0000-0001-9497-3468
dc.authoridVardı, Nigar/0000-0003-0576-1696
dc.authoridÇOLAK, CEMİL/0000-0001-5406-098X
dc.authoridOzhan, Onural/0000-0001-9018-7849
dc.authorwosidErmis, Necip/HJP-7061-2023
dc.authorwosidulutas, zeynep/AAJ-8248-2020
dc.authorwosidErmis, Necip/A-5184-2018
dc.authorwosidUlutaş, Zeynep/JMB-6092-2023
dc.authorwosidParlakpinar, Hakan/V-6637-2019
dc.authorwosidParlakpınar, Hakan/T-6517-2018
dc.authorwosidVardı, Nigar/C-9549-2018
dc.contributor.authorErmis, N.
dc.contributor.authorOzhan, O.
dc.contributor.authorUlutas, Z.
dc.contributor.authorVardi, N.
dc.contributor.authorColak, C.
dc.contributor.authorParlakpinar, H.
dc.date.accessioned2024-08-04T21:01:23Z
dc.date.available2024-08-04T21:01:23Z
dc.date.issued2016
dc.departmentİnönü Üniversitesien_US
dc.descriptionCongress of the European-Society-of-Cardiology (ESC) -- AUG 27-31, 2016 -- Rome, ITALYen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipEuropean Soc Cardiolen_US
dc.identifier.endpage1318en_US
dc.identifier.issn0195-668X
dc.identifier.issn1522-9645
dc.identifier.startpage1318en_US
dc.identifier.urihttps://hdl.handle.net/11616/104321
dc.identifier.volume37en_US
dc.identifier.wosWOS:000383869506405en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherOxford Univ Pressen_US
dc.relation.ispartofEuropean Heart Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleThe effect of angiotensin II type 2 receptor agonist treatment on doxorubicin induced heart failureen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu